These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 38573131)

  • 21. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
    Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A
    Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of adjunctive cenobamate: Post-hoc analysis of study C017 in patients grouped by mechanism of action of concomitant antiseizure medications.
    Brandt C; Sánchez-Álvarez JC; Steinhoff BJ; Milanov I; Serratosa JM
    Seizure; 2022 Mar; 96():86-93. PubMed ID: 35168142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cenobamate tablets as a treatment for focal-onset seizures in adults.
    Steinhoff BJ
    Expert Rev Clin Pharmacol; 2021 Feb; 14(2):161-172. PubMed ID: 33470139
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of cenobamate for the treatment of focal epilepsy: an Italian expert opinion paper.
    Villani F; Cianci V; Di Bonaventura C; Di Gennaro G; Galimberti CA; Guerrini R; La Neve A; Mecarelli O; Pietrafusa N; Specchio N; Vigevano F; Perucca E
    Expert Rev Neurother; 2022; 22(11-12):935-940. PubMed ID: 36662573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is Cenobamate the Breakthrough We Have Been Wishing for?
    Specchio N; Pietrafusa N; Vigevano F
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures: Open-label extension of a randomized clinical study.
    French JA; Chung SS; Krauss GL; Lee SK; Maciejowski M; Rosenfeld WE; Sperling MR; Kamin M
    Epilepsia; 2021 Sep; 62(9):2142-2150. PubMed ID: 34254673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of adjunctive cenobamate based on patient etiology: Post-hoc analysis of YKP3089C017 randomized clinical trial.
    Xu J; Wei W; Liu Y; Ye H; Liu X
    Seizure; 2024 May; 118():95-102. PubMed ID: 38652999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of cenobamate for uncontrolled focal seizures: Post hoc analysis of a Phase 3, multicenter, open-label study.
    Sperling MR; Abou-Khalil B; Aboumatar S; Bhatia P; Biton V; Klein P; Krauss GL; Vossler DG; Wechsler R; Ferrari L; Grall M; Rosenfeld WE
    Epilepsia; 2021 Dec; 62(12):3005-3015. PubMed ID: 34633084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program.
    Roberti R; Assenza G; Bisulli F; Boero G; Canafoglia L; Chiesa V; Di Bonaventura C; Di Gennaro G; Elia M; Ferlazzo E; Giordano A; La Neve A; Liguori C; Meletti S; Operto FF; Pietrafusa N; Puligheddu M; Pulitano P; Rosati E; Sammarra I; Tartara E; Vatti G; Villani F; ; Russo E; Lattanzi S
    Epilepsia; 2024 Oct; 65(10):2909-2922. PubMed ID: 39140704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cenobamate: A New Adjunctive Agent for Drug-Resistant Focal Onset Epilepsy.
    Buckley CT; Waters OR; DeMaagd G
    Ann Pharmacother; 2021 Mar; 55(3):318-329. PubMed ID: 32623899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: A single-center retrospective study.
    Varughese RT; Shah YD; Karkare S; Kothare SV
    Epilepsy Behav; 2022 May; 130():108679. PubMed ID: 35381496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
    Löscher W; Klein P
    CNS Drugs; 2021 Sep; 35(9):935-963. PubMed ID: 34145528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial.
    Krauss GL; Klein P; Brandt C; Lee SK; Milanov I; Milovanovic M; Steinhoff BJ; Kamin M
    Lancet Neurol; 2020 Jan; 19(1):38-48. PubMed ID: 31734103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
    Privitera M; Richy FF; Schabert VF
    Epilepsy Behav; 2022 Jan; 126():108429. PubMed ID: 34864380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cenobamate for the treatment of focal epilepsies.
    Strzelczyk A; Mann C; Willems LM; Rosenow F; Bauer S
    Expert Opin Pharmacother; 2020 Dec; 21(18):2215-2223. PubMed ID: 32812825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cenobamate (XCOPRI): Can preclinical and clinical evidence provide insight into its mechanism of action?
    Guignet M; Campbell A; White HS
    Epilepsia; 2020 Nov; 61(11):2329-2339. PubMed ID: 33063849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
    Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F
    Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study.
    Abou-Khalil B; Aboumatar S; Klein P; Krauss GL; Sperling MR; Rosenfeld WE
    Epilepsy Res; 2022 Aug; 184():106952. PubMed ID: 35671632
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cenobamate in patients with highly refractory focal epilepsy: A retrospective real-world study.
    Beltrán-Corbellini Á; Romeral-Jiménez M; Mayo P; Sánchez-Miranda Román I; Iruzubieta P; Chico-García JL; Parra-Díaz P; García-Morales I; Toledano R; Aledo-Serrano Á; Gil-Nagel A
    Seizure; 2023 Oct; 111():71-77. PubMed ID: 37549616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.